Skip to content Skip to footer

International Cannabis Weekly: 377

November 29, 2024

Highlights

Share this story
Highlights

A NEW ERA FOR MEDICAL CANNABIS IN DENMARK AS GOVERNMENT ANNOUNCES LEGALISATION PLANS

Denmark’s six-year medical cannabis pilot scheme could soon be expanded into a fully legalised market, following a surprise announcement from the government last week.

READ MORE  »

NEW DRAFT OF U.S. FARM BILL INCLUDES MAJOR CHANGES TO HEMP REGULATIONS

READ MORE »

CZECH GPs WILL BE ABLE TO PRESCRIBE MEDICAL CANNABIS STARTING FROM NEXT YEAR

READ MORE »

Highlights

Share this story
Europe

Highlights

Share this story
New Report

Highlights

Share this story
United States
  • LeafLink acquires Leaf Trade in landmark deal slated to generate US$9 billion in annual revenues.
  • Kentucky to launch its long-awaited medicinal cannabis program next month more than a year after legalisation.
  • Motion to remove DEA as proponent of cannabis rescheduling hearing dismissed by judge.
  • Acreage announces expectation to be acquired by Canopy USA in mid-December.
  • Florida’s medical cannabis industry to nearly double as first licences issued in 5 years.
  • Democratic congressional lawmakers push Biden to issue marijuana executive order before Trump takes office.

Highlights

Share this story
Canada

Highlights

Share this story
LATAM & The Caribbean

Highlights

Share this story
APAC

Highlights

Share this story
Africa & The Middle East
  • Cannabis trade dispute between Israel and Canada escalates amid allegations of flawed tariff methodology.
  • South Africa’s cannabis master plan moved from agriculture to the trade and industry ministry to drive growth.
Latest Issues

Insights

on the global cannabis industry

International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.

Market Briefing Request

Please complete your details and a representative will be in contact

In Depth Analysis Session Request

Please complete your details and a representative will be in contact

Data Access Request

Please complete your details and a representative will be in contact